Skip to main content
Top
Published in: Inflammation 2/2011

01-04-2011

Calgranulin B (S100A9/MRP14): A Key Molecule in Idiopathic Pulmonary Fibrosis?

Authors: Elena Bargagli, Carmela Olivieri, Marcella Cintorino, Rosa M. Refini, Nicola Bianchi, Antje Prasse, Paola Rottoli

Published in: Inflammation | Issue 2/2011

Login to get access

Abstract

Calgranulin B is a small calcium-binding protein with several immunological functions mainly involved in chronic inflammation and cancer. It can participate in recruitment of neutrophils and leukocytes in inflamed tissue, oxidant/antioxidant balance, adhesion of neutrophils to fibronectin, and regulation of apoptosis. In a previous proteomic study, we found that calgranulin B was up-regulated in the bronchoalveolar lavage (BAL) of patients with idiopathic pulmonary fibrosis (IPF) with respect to controls and patients with other interstitial lung diseases. The aims of this study are to compare calgranulin B concentrations in BAL of patients with IPF and sarcoidosis and controls by a quantitative method, to look for correlations with clinical data, and to evaluate calgranulin B expression in lung tissue of IPF patients by immunohistochemistry. A modification of a commercial ELISA was used to determine calgranulin B concentrations in BAL of 16 patients with IPF (a group of patients in which we previously performed proteomic analysis), 17 patients with sarcoidosis, and 7 controls. The immunohistochemistry was done in a subgroup of patients with IPF and a control group of lung transplant donors. Calgranulin B concentrations were significantly higher in patients with IPF than controls (p < 0.01); they were inversely correlated with FVC and DLCO values and directly correlated with neutrophil and eosinophil percentages in BAL. Immunohistochemistry revealed a patchy distribution of calgranulin B, predominantly around areas of fibrotic remodeling. Calgranulin B may be a trigger molecule involved in the evolution and progression of IPF, being overexpressed in BAL of patients with IPF with severe functional deterioration and in the peribronchiolar area bordering zones of honeycombing.
Literature
1.
go back to reference Foell, D., H. Wittkowski, T. Vogl, and J. Roth. 2007. S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. Journal of Leukocyte Biology 81: 28–37.PubMedCrossRef Foell, D., H. Wittkowski, T. Vogl, and J. Roth. 2007. S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. Journal of Leukocyte Biology 81: 28–37.PubMedCrossRef
2.
go back to reference Lagasse, E., and R.C. Clerc. 1988. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Molecular and Cellular Biology 8: 2402–2410.PubMed Lagasse, E., and R.C. Clerc. 1988. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Molecular and Cellular Biology 8: 2402–2410.PubMed
3.
go back to reference Roth, J., S. Teigelkamp, et al. 1992. Complex pattern of myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 186: 304–314.PubMed Roth, J., S. Teigelkamp, et al. 1992. Complex pattern of myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 186: 304–314.PubMed
4.
go back to reference Lorenz, E., M.S. Muhlebach, P.A. Tessier, et al. 2008. Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Respiratory Medicine 102: 567–573.PubMedCrossRef Lorenz, E., M.S. Muhlebach, P.A. Tessier, et al. 2008. Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Respiratory Medicine 102: 567–573.PubMedCrossRef
5.
go back to reference Ryckman, C., K. Vandal, P. Rouleau, et al. 2001. Proinflammatory activitiesof S100: Proteins S100A8, S100A9 and S100A8/A9 induce neutrophil chemotaxis and adhesion. Journal of Immunology 166: 4678–4688. Ryckman, C., K. Vandal, P. Rouleau, et al. 2001. Proinflammatory activitiesof S100: Proteins S100A8, S100A9 and S100A8/A9 induce neutrophil chemotaxis and adhesion. Journal of Immunology 166: 4678–4688.
6.
go back to reference Gebhardt, C., J. Nemeth, P. Angel, and J. Hess. 2006. S100A8 and S100A9 in inflammation and cancer. Biochemical Pharmacology 72: 1622–1631.PubMedCrossRef Gebhardt, C., J. Nemeth, P. Angel, and J. Hess. 2006. S100A8 and S100A9 in inflammation and cancer. Biochemical Pharmacology 72: 1622–1631.PubMedCrossRef
7.
go back to reference Foell, D., and J. Roth. 2004. Proinflammatory S100 proteins in arthritis and autoimmune diseases. Arthritis and Rheumatism 50: 3762–3771.PubMedCrossRef Foell, D., and J. Roth. 2004. Proinflammatory S100 proteins in arthritis and autoimmune diseases. Arthritis and Rheumatism 50: 3762–3771.PubMedCrossRef
8.
go back to reference Kosaki, A., T. Hagegawa, T. Kinura, et al. 2004. Increased plasma S100A12 levels in patients with type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism 89: 5423–5428.PubMedCrossRef Kosaki, A., T. Hagegawa, T. Kinura, et al. 2004. Increased plasma S100A12 levels in patients with type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism 89: 5423–5428.PubMedCrossRef
9.
go back to reference Odink, K., N. Cerletti, J. Bruggen, et al. 1987. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80–82.PubMedCrossRef Odink, K., N. Cerletti, J. Bruggen, et al. 1987. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80–82.PubMedCrossRef
10.
go back to reference Haga, H.J., J. Brun, H.B. Berntzen, et al. 1993. Calprotectin in patients with SLE: Relation with clinical and laboratory parameters of disease activity. Lupus 2: 47–50.PubMed Haga, H.J., J. Brun, H.B. Berntzen, et al. 1993. Calprotectin in patients with SLE: Relation with clinical and laboratory parameters of disease activity. Lupus 2: 47–50.PubMed
11.
go back to reference Schnekenburger, J., V. Schick, and B. Kruger, et al. 2008. The calcium-binding protein S100A9 is essential for pancreatic leukocyte infiltration and induces disruption of cell–cell contacts. Journal of Cellular Physiology 216: 558–567.PubMedCrossRef Schnekenburger, J., V. Schick, and B. Kruger, et al. 2008. The calcium-binding protein S100A9 is essential for pancreatic leukocyte infiltration and induces disruption of cell–cell contacts. Journal of Cellular Physiology 216: 558–567.PubMedCrossRef
12.
go back to reference Yoo, B.C., Y.K. Shin, S.B. Lim, et al. 2008. Evaluation of calgranulin B in stools from the patients with colorectal cancer. Diseases of the Colon & Rectum 51: 1703–1709. Yoo, B.C., Y.K. Shin, S.B. Lim, et al. 2008. Evaluation of calgranulin B in stools from the patients with colorectal cancer. Diseases of the Colon & Rectum 51: 1703–1709.
13.
go back to reference Heizmann, C.W., G.E. Ackermann, and A. Galichet. 2007. Pathologies involving S100 proteins and RAGE. Subcellular Biochemistry 45: 93–138.PubMedCrossRef Heizmann, C.W., G.E. Ackermann, and A. Galichet. 2007. Pathologies involving S100 proteins and RAGE. Subcellular Biochemistry 45: 93–138.PubMedCrossRef
14.
go back to reference Wilkinson, M.M., A. Busuttil, C. Hayward, et al. 1988. Expression pattern of related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. Journal of Cell Science 91: 221–230.PubMed Wilkinson, M.M., A. Busuttil, C. Hayward, et al. 1988. Expression pattern of related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. Journal of Cell Science 91: 221–230.PubMed
15.
go back to reference Pederson, S.K., A.J. Sloane, S.S. Prasad, et al. 2005. An immunoproteomic approach for identification of clinical biomarkers formonitoring disease: Application to cystic fibrosis. Molecular & Cellular Proteomics 4: 1052–1060.CrossRef Pederson, S.K., A.J. Sloane, S.S. Prasad, et al. 2005. An immunoproteomic approach for identification of clinical biomarkers formonitoring disease: Application to cystic fibrosis. Molecular & Cellular Proteomics 4: 1052–1060.CrossRef
16.
go back to reference Gray, R.D., G. Macgregor, D. Noble, et al. 2008. Sputum proteomics in inflammatory and suppurative respiratory diseases. American Journal of Respiratory and Critical Care Medicine 178: 444–452. Gray, R.D., G. Macgregor, D. Noble, et al. 2008. Sputum proteomics in inflammatory and suppurative respiratory diseases. American Journal of Respiratory and Critical Care Medicine 178: 444–452.
17.
go back to reference Longbottom, D., J.M. Sallenave, and V. van Heyningen. 1992. Subunit structure of calgranulin A and B obtained from sputum, plasma, granulocytes and cultured epithelial cells. Biochimica et Biophysica Acta 1120: 215–222.PubMedCrossRef Longbottom, D., J.M. Sallenave, and V. van Heyningen. 1992. Subunit structure of calgranulin A and B obtained from sputum, plasma, granulocytes and cultured epithelial cells. Biochimica et Biophysica Acta 1120: 215–222.PubMedCrossRef
18.
go back to reference Foell, D., T. Kucharzik, and M. Kraft. 2003. et al Neutrophil-derived human S100A12 is strongly expressed during chronic active inflammatory bowel disease. Gut 52: 847–853.PubMedCrossRef Foell, D., T. Kucharzik, and M. Kraft. 2003. et al Neutrophil-derived human S100A12 is strongly expressed during chronic active inflammatory bowel disease. Gut 52: 847–853.PubMedCrossRef
19.
go back to reference Magi, B., L. Bini, M.G. Perari, et al. 2002. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: A two dimensional electrophoretic study. Electrophoresis 23: 3434–3444.PubMedCrossRef Magi, B., L. Bini, M.G. Perari, et al. 2002. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: A two dimensional electrophoretic study. Electrophoresis 23: 3434–3444.PubMedCrossRef
20.
go back to reference Rottoli, P., B. Magi, M.G. Perari, S. Liberatori, et al. 2005. Cytokine profile and protome analysis in broncoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiophatic pulmonary fibrosis. Proteomics 5: 1423–1430.PubMedCrossRef Rottoli, P., B. Magi, M.G. Perari, S. Liberatori, et al. 2005. Cytokine profile and protome analysis in broncoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiophatic pulmonary fibrosis. Proteomics 5: 1423–1430.PubMedCrossRef
21.
go back to reference Bargagli E, C Olivieri, A Prasse, et al. 2008. Calgranulin B in BAL of patients with interstitial lung diseases. Inflammation 31: 351–354. Bargagli E, C Olivieri, A Prasse, et al. 2008. Calgranulin B in BAL of patients with interstitial lung diseases. Inflammation 31: 351–354.
22.
go back to reference Magi, B., E. Bargagli, L. Bini, and P. Rottoli. 2006. Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics 6(23): 6354–6369.PubMedCrossRef Magi, B., E. Bargagli, L. Bini, and P. Rottoli. 2006. Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics 6(23): 6354–6369.PubMedCrossRef
23.
go back to reference American Thoracic Society ATS. 2002. Society, ERS. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. American Journal of Respiratory and Critical Care Medicine 165: 227–304. American Thoracic Society ATS. 2002. Society, ERS. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. American Journal of Respiratory and Critical Care Medicine 165: 227–304.
24.
go back to reference Hunninghake, G.W., U. Costabel, M. Ando, et al. 1999. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 16: 149–173.PubMed Hunninghake, G.W., U. Costabel, M. Ando, et al. 1999. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 16: 149–173.PubMed
25.
go back to reference Ziegenhagen, M.W., M.E. Rothe, and M. Schlaak. 2003. Muller-Quernheim: BAL and serologial parameters reflecting the severity of sarcoidosis. The European Respiratory Journal 21: 407–413.PubMedCrossRef Ziegenhagen, M.W., M.E. Rothe, and M. Schlaak. 2003. Muller-Quernheim: BAL and serologial parameters reflecting the severity of sarcoidosis. The European Respiratory Journal 21: 407–413.PubMedCrossRef
26.
go back to reference Hunninghake, G.W., S. Gilbert, R. Pueringer, et al. 1994. Outcome of the treatment of sarcoidosis. American Journal of Respiratory and Critical Care Medicine 149: 893–898.PubMed Hunninghake, G.W., S. Gilbert, R. Pueringer, et al. 1994. Outcome of the treatment of sarcoidosis. American Journal of Respiratory and Critical Care Medicine 149: 893–898.PubMed
27.
go back to reference Bargagli, E., C. Bigliazzi, A. Leonini, N. Nikiforakis, M.G. Perari, and P. Rottoli. 2005. Tryptase concentrations in bronchoalveolar lavage from patients with chronic eosinophilic pneumonia. Clinical Science (London) 108(3): 273–276.CrossRef Bargagli, E., C. Bigliazzi, A. Leonini, N. Nikiforakis, M.G. Perari, and P. Rottoli. 2005. Tryptase concentrations in bronchoalveolar lavage from patients with chronic eosinophilic pneumonia. Clinical Science (London) 108(3): 273–276.CrossRef
28.
go back to reference Bargagli, E., M. Margollicci, M. Perrone, A. Luddi, N. Bianchi, L. Volterrani, M.G. Perari, S. Grosso, and P. Rottoli. 2007. Chitotriosidase levels in BAL of patients with sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 24: 59–64.PubMed Bargagli, E., M. Margollicci, M. Perrone, A. Luddi, N. Bianchi, L. Volterrani, M.G. Perari, S. Grosso, and P. Rottoli. 2007. Chitotriosidase levels in BAL of patients with sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 24: 59–64.PubMed
29.
go back to reference Bradford, M.M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248–254.PubMedCrossRef Bradford, M.M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248–254.PubMedCrossRef
30.
go back to reference Selman, M., T.E. King, A. Pardo, et al. 2001. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Annals of Internal Medicine 134: 136–151.PubMed Selman, M., T.E. King, A. Pardo, et al. 2001. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Annals of Internal Medicine 134: 136–151.PubMed
31.
go back to reference Hallgren, R., L. Bjermer, R. Lundgren, and P. Venge. 1989. The eosinophil component of the alveolitis in idiophatic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. The American Review of Respiratory Disease 139: 373–377.PubMed Hallgren, R., L. Bjermer, R. Lundgren, and P. Venge. 1989. The eosinophil component of the alveolitis in idiophatic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. The American Review of Respiratory Disease 139: 373–377.PubMed
32.
go back to reference Kuwano, K., N. Nakashima, I. Inoshima, et al. 2003. Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. The European Respiratory Journal 21: 232–240.PubMedCrossRef Kuwano, K., N. Nakashima, I. Inoshima, et al. 2003. Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. The European Respiratory Journal 21: 232–240.PubMedCrossRef
33.
go back to reference Veeraraghavan, S., P.I. Latsi, A.U. Wells, et al. 2003. BAL findings in NSIP and UIP. The European Respiratory Journal 22: 239–244.PubMedCrossRef Veeraraghavan, S., P.I. Latsi, A.U. Wells, et al. 2003. BAL findings in NSIP and UIP. The European Respiratory Journal 22: 239–244.PubMedCrossRef
34.
go back to reference Anceriz, N., and K. Vandal. 2007. Tessier P.A. S100A9 mediates neutrophil adhesion to fibronectin to activation of beta2-integrins. Biochemical and Biophysical Research Communications 354: 84–89.PubMedCrossRef Anceriz, N., and K. Vandal. 2007. Tessier P.A. S100A9 mediates neutrophil adhesion to fibronectin to activation of beta2-integrins. Biochemical and Biophysical Research Communications 354: 84–89.PubMedCrossRef
35.
go back to reference Queisser, M.A., F.M. Kouri, M. Konigshoff et al. 2008. Loss of RAGE in pulmonary fibrosis: Molecular relations to functional changes in pulmonary cell types. American Journal of Respiratory Cell and Molecular Biology. Epub. Queisser, M.A., F.M. Kouri, M. Konigshoff et al. 2008. Loss of RAGE in pulmonary fibrosis: Molecular relations to functional changes in pulmonary cell types. American Journal of Respiratory Cell and Molecular Biology. Epub.
36.
go back to reference Englert, J.M., L.E. Hanford, N. Kaminski, J.M. Tobolewski, R.J. Tan, C.L. Fattman, L. Ramsgaard, T.J. Richards, I. Loutaev, P.P. Nawroth, M. Kasper, A. Bierhaus, and T.D. Oury. 2008. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. The American Journal of Pathology 172(3): 583–591.PubMedCrossRef Englert, J.M., L.E. Hanford, N. Kaminski, J.M. Tobolewski, R.J. Tan, C.L. Fattman, L. Ramsgaard, T.J. Richards, I. Loutaev, P.P. Nawroth, M. Kasper, A. Bierhaus, and T.D. Oury. 2008. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. The American Journal of Pathology 172(3): 583–591.PubMedCrossRef
37.
go back to reference He, M., H. Kubo, K. Ishizawa, A.E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya. 2007. The role of the receptor for advanced glycation end-products in lung fibrosis. American Journal of Physiology. Lung Cellular and Molecular Physiology 293(6): L1427–L1436.PubMedCrossRef He, M., H. Kubo, K. Ishizawa, A.E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya. 2007. The role of the receptor for advanced glycation end-products in lung fibrosis. American Journal of Physiology. Lung Cellular and Molecular Physiology 293(6): L1427–L1436.PubMedCrossRef
38.
go back to reference Morbini, P., C. Villa, I. Campo, M. Zorzetto, S. Inghilleri, and M. Luisetti. 2006. The receptor for advanced glycation end products and its ligands: A new inflammatory pathway in lung disease? Modern Pathology 19(11): 1437–1445.PubMed Morbini, P., C. Villa, I. Campo, M. Zorzetto, S. Inghilleri, and M. Luisetti. 2006. The receptor for advanced glycation end products and its ligands: A new inflammatory pathway in lung disease? Modern Pathology 19(11): 1437–1445.PubMed
39.
go back to reference Fernández Pérez, E.R., C.E. Daniels, et al. 2009. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: A population-based study. Chest. Fernández Pérez, E.R., C.E. Daniels, et al. 2009. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: A population-based study. Chest.
40.
go back to reference Kottmann, R.M., C.M. Hogan, R.P. Phipps, and P.J. Sime. 2009. Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology 14: 917–933.PubMedCrossRef Kottmann, R.M., C.M. Hogan, R.P. Phipps, and P.J. Sime. 2009. Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology 14: 917–933.PubMedCrossRef
41.
go back to reference Zappala, C.J., P.I. Latsi and A.G. Nicholson, et al. 2009. Marginal decline in FVC is associated with a poor outcome in IPF. European Respiratory Journal. Zappala, C.J., P.I. Latsi and A.G. Nicholson, et al. 2009. Marginal decline in FVC is associated with a poor outcome in IPF. European Respiratory Journal.
Metadata
Title
Calgranulin B (S100A9/MRP14): A Key Molecule in Idiopathic Pulmonary Fibrosis?
Authors
Elena Bargagli
Carmela Olivieri
Marcella Cintorino
Rosa M. Refini
Nicola Bianchi
Antje Prasse
Paola Rottoli
Publication date
01-04-2011
Publisher
Springer US
Published in
Inflammation / Issue 2/2011
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-010-9210-7

Other articles of this Issue 2/2011

Inflammation 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.